Because the automatic implantable defibrillator may be used in patients having ischemic heart disease, it is important to know whether myocardial ischemia changes the threshold for ventricular defibrillation under experimental conditions simulating automatic internal defibrillation. We determined changes in ventricular defibrillation threshold following coronary occlusion, using an electrode catheter designed for use with an automatic implantable defibrillator. Acute myocardial ischemia was produced without thoracotomy in 10 dogs (experimental group) by embolization with a plastic bead injected via a catheter into the left coronary artery. A control group of 4 dogs had only saline injected into the artery. Defibrillation threshold was measu...
AbstractThe effect of ventricular fibrillation duration in humans on defibrillation efficacy as it p...
AbstractThe arrhythinogenic effect of acute reversible myocardial ischemia before and 2 weeks after ...
Since the introduction of the implantable cardioverter defibrillator for humans with malignant ventr...
AbstractObjectives. This study investigated the effects of acute global ischemia on the vulnerable w...
AbstractObjectivesThe goal of this study was to determine if the defibrillation threshold (DFT) afte...
AbstractThe effects of transthoracic and internal defibrillation on the bipolar ventricular pacing t...
OBJECTIVES The goal of this study was to determine if the defibrillation threshold (DFT) after spont...
Effects of antiarrhythmic drugs upon the threshold delivered energy (TDE) and threshold peak current...
THE commonest cause of death followingcoronary occlusion, certainly in the ex-perimental animal if n...
The automatic implantable cardioverter/defibrillator is tested intraoperatively to ensure effectiven...
In anesthetized dogs, a 30 gauge silver wire was inserted into the lumen of the left circumflex (LC)...
Data from numerous experimental infarction studies indicate that rapid myocardial cell depolarizatio...
This study was conducted to determine whether or not hypothermia changes ventricular defibrillation ...
The relationship between inducible ventricular tachycardia in the convalescent phase of myocardial i...
Aims: To investigate the hemodynamic, metabolic and autonomic effects of ventricular fibrillation pe...
AbstractThe effect of ventricular fibrillation duration in humans on defibrillation efficacy as it p...
AbstractThe arrhythinogenic effect of acute reversible myocardial ischemia before and 2 weeks after ...
Since the introduction of the implantable cardioverter defibrillator for humans with malignant ventr...
AbstractObjectives. This study investigated the effects of acute global ischemia on the vulnerable w...
AbstractObjectivesThe goal of this study was to determine if the defibrillation threshold (DFT) afte...
AbstractThe effects of transthoracic and internal defibrillation on the bipolar ventricular pacing t...
OBJECTIVES The goal of this study was to determine if the defibrillation threshold (DFT) after spont...
Effects of antiarrhythmic drugs upon the threshold delivered energy (TDE) and threshold peak current...
THE commonest cause of death followingcoronary occlusion, certainly in the ex-perimental animal if n...
The automatic implantable cardioverter/defibrillator is tested intraoperatively to ensure effectiven...
In anesthetized dogs, a 30 gauge silver wire was inserted into the lumen of the left circumflex (LC)...
Data from numerous experimental infarction studies indicate that rapid myocardial cell depolarizatio...
This study was conducted to determine whether or not hypothermia changes ventricular defibrillation ...
The relationship between inducible ventricular tachycardia in the convalescent phase of myocardial i...
Aims: To investigate the hemodynamic, metabolic and autonomic effects of ventricular fibrillation pe...
AbstractThe effect of ventricular fibrillation duration in humans on defibrillation efficacy as it p...
AbstractThe arrhythinogenic effect of acute reversible myocardial ischemia before and 2 weeks after ...
Since the introduction of the implantable cardioverter defibrillator for humans with malignant ventr...